Nobel Laureate Prof. Aaron Ciechanover addressed the first ProUPS Conference at SRMIST. The event, centered on protein homeostasis and its impact on health and drug discovery, featured international ...

An international team of researchers have introduced a groundbreaking drug, known as the covalent kinase inhibitor, which shows promise in combating treatment-resistant malaria.Developed by chemists ...

A team from the University of Washington led by Nobel laureate David Baker is using artificial intelligence to design ...

Professor Bernard Carroll from UQ’s School of Chemistry and Molecular Biosciences said nanoparticle technology could help ...

Nobel Laureate Prof. Aaron Ciechanover (2004, Chemistry) delivered a special address at the inaugural of ProUPS (Proteostasis ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

Latent Labs hopes to take computational biology one step further. The company is developing foundation AI models that don’t ...

Covalent bonding is a widely understood phenomenon that joins the atoms of a molecule by a shared electron pair. But in ...

Liverpool researchers' discovery of collagen in fossilized bones could provide new insights into dinosaurs. For years, ...

High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to ...

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...